Patent Litigation | Intellepedia

World’s Best IP Blogs – Patent Docs

Patent Docs is a leading source for biotech and pharma patent law updates, offering expert analyses and timely news. Authored by experienced practitioners, it serves as an essential reference for patent professionals and attorneys.

Prosecution History Estoppel

The doctrine of prosecution history estoppel shapes how patent claims are interpreted following amendments made during prosecution. This analysis covers its application in India, focusing on the challenges it presents for patentees and practitioners.

Patent trolls – Lesson No. 1

The article examines patent trolls and their impact on the patent landscape in the US and India. It analyses the difference in litigation practices and the effect of compulsory licensing on curbing trolling activities, especially in the software sector.

Role of a Scientific Advisor/ Expert in Patent litigation

Scientific advisors play a pivotal role in patent litigation by clarifying complex technical issues for the court. Their expertise aids in interpreting patent claims, assessing infringement, and influencing judicial decisions, as demonstrated in significant Indian patent cases.

Standard-Essential Patents & FRAND licensing in India

This post analyses the legal and industry dynamics of standard essential patents and FRAND licensing in India. It covers key cases, policy challenges, and the complexities of balancing SEP holder and licensee interests in the Indian context.

What a Wonderful World!

The article discusses Google and Microsoft’s decision to resolve all pending patent disputes, signalling a shift towards collaboration in the technology sector. This development is analysed within the broader context of global patent litigation trends and their implications for innovation.

Mylan settles Patent Litigation with Pfizer

Mylan has reached a settlement with Pfizer over patent litigation related to Sildenafil, allowing earlier generic market entry in the US. This agreement is expected to lower drug prices and may signal a trend for further settlements involving Indian pharmaceutical companies.

IBM sues Priceline and subsidiaries for Patent Infringement

IBM has sued Priceline and its subsidiaries for allegedly infringing five patents related to online technologies. The case underscores IBM’s ongoing efforts to enforce its intellectual property rights and secure licensing revenue.

Xiaomi maintains competitive pricing; Removes onus of Royalties on customers

Xiaomi faces a patent dispute in India but continues to offer competitively priced smartphones. The company leverages its agreements with Qualcomm and focuses on risk mitigation while maintaining its commitment to Indian customers.

IEEE amends it’s IP policy related to Standard Essential Patents

IEEE has amended its IP policy for Standard Essential Patents, requiring RAND licensing and setting limits on injunctions. The clarified definition of reasonable terms is expected to reduce litigation and encourage fair negotiations in the telecommunications industry.